{"entity":{"id":"nct06793553","kind":"trial","name":"Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC","aka":["INDUCE"],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Japan Breast Cancer Research Group, now recruiting.","summary":"Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC is a phase 2, randomised interventional study registered as NCT06793553 by Japan Breast Cancer Research Group, with a registry enrolment figure of 106 participants, started 2024-09-13 and due to reach its primary completion in 2026-03-31. Interventions recorded: Induction therapy. Conditions listed: Metastatic Breast Cancer. Triple-negative eligibility wording from the registry: \"Diagnosed with metastatic recurrent or unresectable advanced TNBC\". Sites: Japan. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06793553","url":"https://clinicaltrials.gov/study/NCT06793553"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early","tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06793553","phase":"2","setting":"Randomized Phase II Trial Evaluating the Efficacy of Paclitaxel+Bevacizumab INDUCtion Followed by at atEzolizumab+Nab-paclitaxel for PD-L1-positive Metastatic Triple Negative Breast Cancer (JBCRG-M10, CMA-0196) (INDUCE Trial)","sponsor":"Japan Breast Cancer Research Group","enrolled":106,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06793553/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"},{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}